- Home
- TLRY vs ASST Comparison
TLRY vs ASST Comparison
Compare TLRY & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLRY
- ASST
- Stock Information
- Founded
- TLRY N/A
- ASST 2020
- Country
- TLRY Canada
- ASST United States
- Employees
- TLRY N/A
- ASST N/A
- Industry
- TLRY Medicinal Chemicals and Botanical Products
- ASST Computer Software: Prepackaged Software
- Sector
- TLRY Health Care
- ASST Technology
- Exchange
- TLRY Nasdaq
- ASST Nasdaq
- Market Cap
- TLRY 1.7B
- ASST 1.7B
- IPO Year
- TLRY 2018
- ASST 2023
- Fundamental
- Price
- TLRY $1.36
- ASST $1.25
- Analyst Decision
- TLRY Buy
- ASST
- Analyst Count
- TLRY 3
- ASST 0
- Target Price
- TLRY $1.50
- ASST N/A
- AVG Volume (30 Days)
- TLRY 94.8M
- ASST 119.0M
- Earning Date
- TLRY 10-09-2025
- ASST 11-13-2025
- Dividend Yield
- TLRY N/A
- ASST N/A
- EPS Growth
- TLRY N/A
- ASST N/A
- EPS
- TLRY N/A
- ASST N/A
- Revenue
- TLRY $830,766,000.00
- ASST $4,953,567.00
- Revenue This Year
- TLRY $7.28
- ASST N/A
- Revenue Next Year
- TLRY $4.56
- ASST N/A
- P/E Ratio
- TLRY N/A
- ASST N/A
- Revenue Growth
- TLRY 2.31
- ASST 49.00
- 52 Week Low
- TLRY $0.35
- ASST $0.34
- 52 Week High
- TLRY $2.32
- ASST $13.42
- Technical
- Relative Strength Index (RSI)
- TLRY 43.86
- ASST 39.17
- Support Level
- TLRY $1.40
- ASST $0.78
- Resistance Level
- TLRY $1.54
- ASST $1.81
- Average True Range (ATR)
- TLRY 0.12
- ASST 0.19
- MACD
- TLRY -0.05
- ASST 0.16
- Stochastic Oscillator
- TLRY 2.99
- ASST 44.34
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
About ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.